SG MEDICS LIMITED

Company Registration Number:
12988096 (England and Wales)

Unaudited abridged accounts for the year ended 30 November 2025

Period of accounts

Start date: 01 December 2024

End date: 30 November 2025

SG MEDICS LIMITED

Contents of the Financial Statements

for the Period Ended 30 November 2025

Balance sheet
Notes

SG MEDICS LIMITED

Balance sheet

As at 30 November 2025


Notes
2025
2024


£
£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets: 3 510,600 542,512
Total fixed assets: 510,600 542,512
Current assets
Debtors:   119,000 109,000
Cash at bank and in hand: 3,680 6,435
Total current assets: 122,680 115,435
Creditors: amounts falling due within one year:   (15,354) (8,676)
Net current assets (liabilities): 107,326 106,759
Total assets less current liabilities: 617,926 649,271
Creditors: amounts falling due after more than one year:   (702,690) (728,689)
Total net assets (liabilities): (84,764) (79,418)
Capital and reserves
Called up share capital: 100 100
Profit and loss account: (84,864) (79,518)
Shareholders funds: (84,764) (79,418)

The notes form part of these financial statements

SG MEDICS LIMITED

Balance sheet statements

For the year ending 30 November 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 26 August 2026
and signed on behalf of the board by:

Name: Gowardhan Kotra
Status: Director

The notes form part of these financial statements

SG MEDICS LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

SG MEDICS LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2025

2. Employees

2025 2024
Average number of employees during the period 2 2

SG MEDICS LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2025

3. Intangible Assets

Total
Cost £
At 01 December 2024 638,250
At 30 November 2025 638,250
Amortisation
At 01 December 2024 95,738
Charge for year 31,912
At 30 November 2025 127,650
Net book value
At 30 November 2025 510,600
At 30 November 2024 542,512